<DOC>
	<DOC>NCT00270426</DOC>
	<brief_summary>The purpose of this study is to further determine whether benazepril, could safely slow the progression of renal dysfunction in non-diabetic patients with advanced renal insufficiency.</brief_summary>
	<brief_title>Benazepril for Advanced Chronic Renal Insufficiency</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<mesh_term>Kidney Failure, Chronic</mesh_term>
	<mesh_term>Benazepril</mesh_term>
	<criteria>1. serum creatinine concentration 1.55.0 mg/dL (133442 µmol/L) 2. creatinine clearance 20 to70 mL/min/1.73 m2, with variations of less than 30 percent in the three months before the screening evaluation 3. nondiabetic renal disease 4. persistent proteinuria (defined as urinary protein excretion greater than 0.3 g/day for three or more months without evidence of urinarytract infection or overt heart failure [New York Heart Association class III–IV]). immediate need for dialysis; treatment with corticosteroids, nonsteroidal antiinflammatory drugs or immunosuppressive drugs; renovascular disease; myocardial infarction or cerebrovascular accident in the year preceding the trial; connectivetissue disease; obstructive uropathy.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 1999</verification_date>
	<keyword>Advanced Chronic Renal Insufficiency</keyword>
	<keyword>Benazepril</keyword>
</DOC>